Zhuo Zhang
Shenyang Medical College(CN)Tongji University(CN)Shandong University of Technology(CN)Jinan University(CN)Northwestern Polytechnical University(CN)Dalian Medical University(CN)Peking University(CN)Zhengzhou University(CN)Chinese Academy of Engineering(CN)Second Affiliated Hospital of Dalian Medical University(CN)Peking University First Hospital(CN)Second Affiliated Hospital of Nanjing Medical University(CN)Wuhan Third Hospital(CN)First Affiliated Hospital of Henan University(CN)Jinzhou Medical University(CN)
Publications by Year
Research Areas
Cancer-related Molecular Pathways, Cancer Cells and Metastasis, HER2/EGFR in Cancer Research, Cancer Immunotherapy and Biomarkers, Cancer Genomics and Diagnostics
Most-Cited Works
- → G1 cell cycle progression and the expression of G1 cyclins are regulated by PI3K/AKT/mTOR/p70S6K1 signaling in human ovarian cancer cells(2004)309 cited
- → Role of PI3K/AKT/mTOR signaling in the cell cycle progression of human prostate cancer(2003)280 cited
- → Curcumin, a Dietary Component, Has Anticancer, Chemosensitization, and Radiosensitization Effects by Down-regulating the MDM2 Oncogene through the PI3K/mTOR/ETS2 Pathway(2007)274 cited
- → MDM2 Is a Negative Regulator of p21 , Independent of p53(2004)258 cited
- → Expansion of CTCs from early stage lung cancer patients using a microfluidic co-culture model(2014)197 cited
- → Antisense therapy targeting MDM2 oncogene in prostate cancer: Effects on proliferation, apoptosis, multiple gene expression, and chemotherapy(2003)